One North Texan makes Modern Healthcare’s 2012 “Up and Comers” list.
Dallas-based MediSend International is providing 50 Nigerian technicians with professional training and technical support.
Engineers at UTD made a material small enough to read DNA, which opens the possibility of using it as a low-cost tool to sequence DNA.
The Dallas Regional Chamber Chamber will host its fourth annual healthcare conference Oct. 17, bringing in experts across the sector’s various industries. Full Story
Tarrant County hospital among those that received contaminated steroids.
MEDPac: Let geographic-based pay cuts for physicians proceed.
The FCC has a plan that could make wireless patient monitoring devices a reality.
The Healthcare industry added 43,500 jobs in September—more than any other sector. Full Story
Six Dallas healthcare professionals have been indicted for defrauding Medicare, as indicted defrauding Medicare part of a national investigation that involves 91 individuals.
Four North Texas leaders have been named to Becker’s Hospital Review’s “100 Women Hospital and Health System Leaders To Know.”
Four months after launching an organ-donation campaign in the United States, Facebook is taking the program to Canada and Mexico.
Novation hosts 50 suppliers at first Innovative Technology Supplier Expo in Irving. Full Story
Meet the first female chief of the medical staff at Texas Health Harris Methodist Hospital Fort Worth.
Healthcare IT News ranks Dallas company No. 2 on its “Where to Work: Top IT Departments” list in the large hospitals category.
Tenet Healthcare’s S&P rating has been cut from ‘BB—’ to ‘B+.”
Nine out of 10 seniors are satisfied with their Medicare prescription drug coverage (Part D). Full Story
A national survey released yesterday found that nine out of 10 seniors are satisfied with their Medicare prescription drug coverage (Part D). The survey, conducted annually by Medicare Today and KRC Research, found that more than eight in 10 seniors find their plan predictable, affordable, reasonable, and offering good value. “[Part D] has become an essential component of seniors’ healthcare,” said Mary R. Grealy, chairman of Medicare Today and president of the Healthcare Leadership Council. The survey shows that overall satisfaction with Part D has increased from 78 percent to 90 percent since the program began. Ninety-six percent say that their… Full Story
Dallas’ Lockton Dunning Benefits makes a “game-changer” acquisition.
Urgent Care for Kids plans expansion after a capital boost from Healthcap.
Report: Drug companies are amping up use of coupons and discount cards to compete with generics.
The U.S. Department of Health and Human Services warns against using EHRs to “game the system.” Full Story
Coupons and discount cards are now available for 395 prescription medications, according to a recent report by IMS Health. A 2009 study reported coupons for only 86 different drugs. Prescription drug companies like AstraZeneca and Pfizer issue coupons that cover high, insurer-set co-pays, which aim to lead consumers to cheaper generics, reports the Washington Post. A recent article in the Journal of the American Medical Association showed that Lipitor had a co-pay of $30, but went down to $4 a month with a coupon. The generic alternative, Simvastatin, cost $10 a month. As for the insurer, Lipitor cost $137 a… Full Story
Prime Healthcare Services has purchased Dallas Medical Center, a 155-bed full service acute-care hospital in Farmers Branch.
Three North Texas companies have made Modern Healthcare’s “Healthcare’s Hottest” list.
Two Dallas clinics have been awarded $500,000 in grants under the GE Foundation’s Developing Health initiative.
The U.S. Supreme Court has taken on three healthcare cases. Full Story
According to the Dallas-based American Heart Association, heart attack victims who take common painkillers, such as ibuprofen, naproxen, and prescription drugs such as Celebrex, run the risk of suffering a second heart attack, as well as an increased chance of death. “It is important to get the message out to clinicians taking care of patients with cardiovascular disease that non-steroidal anti-inflammatory drugs (NSAIDs) are harmful, even several years after a heart attack,” said Anne-Marie Schjerning Olsen, M.D. at Copenhagen University Hospital Gentofte at Denmark, in a statement. In the study, Schjerning Olsen and her colleagues found that 44 percent of patients… Full Story
Taking aspirin is associated with a lower risk of death from prostate cancer, especially in men with high-risk disease. Preclinical studies have shown that aspirin and other anticoagulation medications may inhibit cancer growth and metastasis. The findings of the multicenter study were published in the Journal of Clinical Oncology. Kevin Choe, assistant professor of radiation oncology at UT Southwestern, is first author of the paper. The study looked at almost 6,000 men in the Cancer of the Prostate Strategic Urologic Research Endeavor database who had prostate cancer treated with surgery or radiotherapy. About 2,200 of the men involved, or 37… Full Story